New Delhi— Healthcare professionals are optimistic about the potential of generative AI (GenAI) to transform the sector, particularly in addressing workforce shortages, rising costs, and administrative burdens. However, a new report reveals that most healthcare organizations are not yet prepared to fully leverage the technology.
The findings come from a recent study by Wolters Kluwer Health, which surveyed physicians, nurses, pharmacists, allied health professionals, and administrators. The report highlights a growing disconnect between the enthusiasm for GenAI and institutional readiness to implement it effectively.
According to the data, 80 percent of respondents identified workflow optimization as a top priority, yet only 63 percent felt confident in their organization’s ability to use GenAI for that purpose.
“GenAI has the potential to be a powerful tool for supporting sustainability in healthcare organizations right now, as well as preparing them for a more efficient future,” said Greg Samios, CEO of Wolters Kluwer Health. “The challenge is developing a strategy that can both optimize current operations and build the digital infrastructure needed to stay competitive. Without a cohesive approach, many organizations risk falling behind.”
The report suggests that GenAI could play a critical role in longstanding issues such as managing prior authorizations (67 percent), electronic health record (EHR) systems (62 percent), cybersecurity (68 percent), and telehealth support (65 percent). Still, adoption remains uneven.
Only 18 percent of respondents said their organizations have formal policies on GenAI use, and just 20 percent reported receiving structured training. This lack of preparedness is contributing to deeper concerns. Over half (57 percent) of healthcare workers worry that excessive reliance on GenAI could diminish clinical decision-making skills. Additionally, 55 percent are concerned about the lack of transparency in GenAI-assisted diagnoses, fearing it could cloud judgment in patient care.
The report underscores the need for clear governance, comprehensive training, and a scalable implementation strategy to ensure GenAI fulfills its promise in healthcare. (Source: IANS)
